Bio-Gene TechnologyBio-Gene Technology
  • Home
  • About Us
    • Board of Directors
    • Governance
    • Collaborators
    • Partners
    • Advisors
    • Target Applications
    • Insecticide market
    • Our Business Model
  • Our Commercial Opportunity
  • Qcide™
  • Flavocide™
  • Investor Relations
    • Corporate Presentations
    • ASX Announcements
    • Media
    • SCIENTIFIC PUBLICATIONS
    • Financial Reports
    • Shareholder Updates
    • Prospectus
  • Contact Us
Press enter to begin your search
  • No menu assigned!
Contact us

ASX Announcements

Here you will find copies of all non-compliance related ASX Announcements made by Bio-Gene (ASX:BGT) since its listing on 29 November 2017.  For a complete list of ASX Announcements go to the ASX website.

Loyalty Options Update
14-02-2018 KEY APPOINTMENTS TO ADVISORY & MANAGEMENT TEAMS
Appendix 4D - Half Year Report - 31 December 2017
31-01-2018 PILOT STUDY SHOWS FLAVOCIDE™ ACTIVITY AGAINST SUSCEPTIBLE AND RESISTANT MOSQUITOS
30-01-2018 Appendix 4C - December 2017
21-12-2017 BIO-GENE – 2018 GOALS AND OBJECTIVES FOLLOWING SUCCESSFUL IPO
19-12-2017 BIO-GENE ANNOUNCES POSITIVE SAFETY RESULTS
11-12-2017 BIO-GENE REPORTS POSITIVE INITIAL EFFICACY RESULTS
04-12-2017 BIO-GENE APPOINTS MR DOUG RATHBONE AS AN ADVISOR
01-12-2017 BIO-GENE EXTENDS RESEARCH COLLABORATION WITH QDAF
30-11-2017 BIO-GENE EXTENDS RESEARCH COLLABORATION WITH CSIRO
29-11-2017 BIO-GENE COMPLETES $7.1M IPO TO LIST ON ASX

© 2018 Bio-Gene Technology. All Rights Reserved.

  • Home
  • About Us
    • Board of Directors
    • Governance
    • Collaborators
    • Partners
    • Advisors
    • Target Applications
    • Insecticide market
    • Our Business Model
  • Our Commercial Opportunity
  • Qcide™
  • Flavocide™
  • Investor Relations
    • Corporate Presentations
    • ASX Announcements
    • Media
    • SCIENTIFIC PUBLICATIONS
    • Financial Reports
    • Shareholder Updates
    • Prospectus
  • Contact Us